Literature DB >> 19879856

A solid-state NMR study of changes in lipid phase induced by membrane-fusogenic LV-peptides.

Prashant Agrawal1, Suzanne Kiihne, Johan Hollander, Mathias Hofmann, Dieter Langosch, Huub de Groot.   

Abstract

Membrane fusion requires restructuring of lipid bilayers mediated by fusogenic membrane proteins. Peptides that correspond to natural transmembrane sequences or that have been designed to mimic them, such as low-complexity "Leu-Val" (LV) peptide sequences, can drive membrane fusion, presumably by disturbing the lipid bilayer structure. Here, we assess how peptides of different fusogenicity affect membrane structure using solid state NMR techniques. We find that the more fusogenic variants induce an unaligned lipid phase component and a large degree of phase separation as observed in (31)P 2D spectra. The data support the idea that fusogenic peptides accumulate PE in a non-bilayer phase which may be critical for the induction of fusion. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879856     DOI: 10.1016/j.bbamem.2009.10.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Residue-specific side-chain packing determines the backbone dynamics of transmembrane model helices.

Authors:  Stefan Quint; Simon Widmaier; David Minde; Daniel Hornburg; Dieter Langosch; Christina Scharnagl
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

2.  Water-protein interactions of an arginine-rich membrane peptide in lipid bilayers investigated by solid-state nuclear magnetic resonance spectroscopy.

Authors:  Shenhui Li; Yongchao Su; Wenbin Luo; Mei Hong
Journal:  J Phys Chem B       Date:  2010-03-25       Impact factor: 2.991

3.  v-SNARE transmembrane domains function as catalysts for vesicle fusion.

Authors:  Madhurima Dhara; Antonio Yarzagaray; Mazen Makke; Barbara Schindeldecker; Yvonne Schwarz; Ahmed Shaaban; Satyan Sharma; Rainer A Böckmann; Manfred Lindau; Ralf Mohrmann; Dieter Bruns
Journal:  Elife       Date:  2016-06-25       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.